(PRDO) Perdoceo Education - Overview
Sector: Consumer Defensive | Industry: Education & Training Services | Exchange: NASDAQ (USA) | Market Cap: 2.131m USD | Total Return: -3.7% in 12m
Avg Turnover: 22.4M
EPS Trend: 94.2%
Qual. Beats: 3
Rev. Trend: 67.0%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Perdoceo Education Corporation (PRDO) provides postsecondary education through its three primary segments: Colorado Technical University (CTU), the American InterContinental University System (AIUS), and the University of St. Augustine for Health Sciences (USAHS). The company focuses on career-oriented disciplines including business, information technology, nursing, and healthcare management, delivered via online, campus-based, and blended learning formats.
The business model relies heavily on proprietary technology, such as the intellipath learning platform, to deliver scalable curriculum to non-traditional students. In the Education Services sector, companies often face high regulatory scrutiny regarding student outcomes and federal funding eligibility. Perdoceo recently expanded its specialized footprint through the acquisition of health science programs, a sector typically characterized by higher tuition stability and strong labor demand.
Investors can evaluate the company’s long-term valuation metrics and historical performance trends on ValueRay. Founded in 1994 and headquartered in Schaumburg, Illinois, the firm rebranded from Career Education Corporation in 2020 to align with its current strategic focus on technology-driven education.
- Enrollment growth in CTU and AIU segments drives core revenue performance
- Department of Education regulatory changes impact Title IV funding eligibility
- Acquisition of University of St. Augustine expands high-margin health science offerings
- Corporate partnerships and digital marketing efficiency determine student acquisition costs
- Federal oversight of for-profit education sector influences long-term valuation multiples
| Net Income: 170.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 3.97 > 1.0 |
| NWC/Revenue: 69.27% < 20% (prev 73.28%; Δ -4.01% < -1%) |
| CFO/TA 0.18 > 3% & CFO 229.5m > Net Income 170.2m |
| Net Debt (-1.18b) to EBITDA (265.8m): -4.45 < 3 |
| Current Ratio: 4.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.4m) vs 12m ago -5.15% < -2% |
| Gross Margin: 71.10% > 18% (prev 0.81%; Δ 7.03k% > 0.5%) |
| Asset Turnover: 66.85% > 50% (prev 57.23%; Δ 9.62% > 0%) |
| Interest Coverage Ratio: 35.92 > 6 (EBITDA TTM 265.8m / Interest Expense TTM 6.31m) |
| A: 0.46 (Total Current Assets 747.3m - Total Current Liabilities 155.2m) / Total Assets 1.29b |
| B: 0.59 (Retained Earnings 762.7m / Total Assets 1.29b) |
| C: 0.18 (EBIT TTM 226.6m / Avg Total Assets 1.28b) |
| D: 2.64 (Book Value of Equity 762.6m / Total Liabilities 288.9m) |
| Altman-Z'' = 8.91 = AAA |
| DSRI: 0.60 (Receivables 39.6m/55.7m, Revenue 854.8m/726.0m) |
| GMI: 1.14 (GM 71.10% / 80.78%) |
| AQI: 0.94 (AQ_t 0.32 / AQ_t-1 0.34) |
| SGI: 1.18 (Revenue 854.8m / 726.0m) |
| TATA: -0.05 (NI 170.2m - CFO 229.5m) / TA 1.29b) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of June 01, 2026, the stock is trading at USD 32.38 with a total of 785,657 shares traded.
Over the past week, the price has changed by -4.14%,
over one month by -4.60%,
over three months by -3.08% and
over the past year by -3.66%.
Perdoceo Education has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PRDO.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 44 | 35.9% |
P/E Trailing = 12.9695
P/E Forward = 10.8932
P/S = 2.4925
P/B = 2.132
P/EG = 0.7265
Revenue TTM = 854.8m USD
EBIT TTM = 226.6m USD
EBITDA TTM = 265.8m USD
Long Term Debt = 46.1m USD (estimated: total debt 60.2m - short term 14.0m)
Short Term Debt = 14.0m USD (from shortTermDebt, last quarter)
Debt = 177.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 117.2m
Net Debt = -1.18b USD (calculated: Debt 177.4m - CCE 1.36b)
Enterprise Value = 948.9m USD (2.13b + Debt 177.4m - CCE 1.36b)
Interest Coverage Ratio = 35.92 (Ebit TTM 226.6m / Interest Expense TTM 6.31m)
EV/FCF = 4.30x (Enterprise Value 948.9m / FCF TTM 220.9m)
FCF Yield = 23.28% (FCF TTM 220.9m / Enterprise Value 948.9m)
FCF Margin = 25.84% (FCF TTM 220.9m / Revenue TTM 854.8m)
Net Margin = 19.91% (Net Income TTM 170.2m / Revenue TTM 854.8m)
Gross Margin = 71.10% ((Revenue TTM 854.8m - Cost of Revenue TTM 247.0m) / Revenue TTM)
Gross Margin QoQ = 74.56% (prev 54.01%)
Tobins Q-Ratio = 0.74 (Enterprise Value 948.9m / Total Assets 1.29b)
Interest Expense / Debt = 3.56% (Interest Expense 6.31m / Debt 177.4m)
Taxrate = 20.81% (14.2m / 68.1m)
NOPAT = 179.5m (EBIT 226.6m * (1 - 20.81%))
Current Ratio = 4.82 (Total Current Assets 747.3m / Total Current Liabilities 155.2m)
Debt / Equity = 0.18 (Debt 177.4m / totalStockholderEquity, last quarter 999.9m)
Debt / EBITDA = -4.45 (Net Debt -1.18b / EBITDA 265.8m)
Debt / FCF = -5.35 (Net Debt -1.18b / FCF TTM 220.9m)
Total Stockholder Equity = 988.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.31% (Net Income 170.2m / Total Assets 1.29b)
RoE = 17.21% (Net Income TTM 170.2m / Total Stockholder Equity 988.7m)
RoCE = 21.90% (EBIT 226.6m / Capital Employed (Equity 988.7m + L.T.Debt 46.1m))
RoIC = 15.86% (NOPAT 179.5m / Invested Capital 1.13b)
WACC = 7.42% (E(2.13b)/V(2.31b) * Re(7.80%) + D(177.4m)/V(2.31b) * Rd(3.56%) * (1-Tc(0.21)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -53.94 | Cagr: -2.52%
[DCF] Terminal Value 77.97% ; FCFF base≈199.4m ; Y1≈228.6m ; Y5≈336.4m
[DCF] Fair Price = 99.57 (EV 5.06b - Net Debt -1.18b = Equity 6.24b / Shares 62.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 94.15 | EPS CAGR: 12.86% | SUE: 3.11 | # QB: 3
Revenue Correlation: 66.99 | Revenue CAGR: 7.02% | SUE: 0.74 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.80 | Chg30d=+5.26% | Revisions=+20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.74 | Chg30d=-2.63% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=3.11 | Chg30d=+1.97% | Revisions=+20% | GrowthEPS=+19.2% | GrowthRev=+2.4%
EPS next Year (2027-12-31): EPS=3.34 | Chg30d=+2.14% | Revisions=+20% | GrowthEPS=+7.4% | GrowthRev=+2.8%